These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21115037)

  • 1. Endothelium-derived vasoactive agents, AT1 receptors and inflammation.
    MacKenzie A
    Pharmacol Ther; 2011 Aug; 131(2):187-203. PubMed ID: 21115037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor.
    Wassmann S; Stumpf M; Strehlow K; Schmid A; Schieffer B; Böhm M; Nickenig G
    Circ Res; 2004 Mar; 94(4):534-41. PubMed ID: 14699015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammation may be a bridge connecting hypertension and atherosclerosis.
    Li JJ; Chen JL
    Med Hypotheses; 2005; 64(5):925-9. PubMed ID: 15780486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Essential hypertension: is there a role for inflammatory mechanisms?
    Androulakis ES; Tousoulis D; Papageorgiou N; Tsioufis C; Kallikazaros I; Stefanadis C
    Cardiol Rev; 2009; 17(5):216-21. PubMed ID: 19690472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of endothelial nitric oxide in the regulation of the vasomotor system].
    Michel JB
    Pathol Biol (Paris); 1998 Mar; 46(3):181-9. PubMed ID: 9769914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiotensin II and vascular inflammation.
    Cheng ZJ; Vapaatalo H; Mervaala E
    Med Sci Monit; 2005 Jun; 11(6):RA194-205. PubMed ID: 15917731
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A rationale for treatment of endothelial dysfunction in hypertension.
    Ruschitzka F; Corti R; Noll G; Lüscher TF
    J Hypertens Suppl; 1999 Feb; 17(1):S25-35. PubMed ID: 10340841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal and vascular hypertension-induced inflammation: role of angiotensin II.
    Ruiz-Ortega M; Esteban V; Rupérez M; Sánchez-López E; Rodríguez-Vita J; Carvajal G; Egido J
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):159-66. PubMed ID: 16481883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of treatment strategy on endothelial function.
    Tomasoni L; Sitia S; Borghi C; Cicero AF; Ceconi C; Cecaro F; Morganti A; De Gennaro Colonna V; Guazzi M; Morricone L; Malavazos AE; Marino P; Cavallino C; Shoenfeld Y; Turiel M
    Autoimmun Rev; 2010 Oct; 9(12):840-4. PubMed ID: 20678593
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does reversal of oxidative stress and inflammation provide vascular protection?
    Koh KK; Oh PC; Quon MJ
    Cardiovasc Res; 2009 Mar; 81(4):649-59. PubMed ID: 19098298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II as a pro-inflammatory mediator.
    Phillips MI; Kagiyama S
    Curr Opin Investig Drugs; 2002 Apr; 3(4):569-77. PubMed ID: 12090726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nitric oxide--the endothelium-derived relaxing factor and its role in endothelial functions.
    Bauer V; Sotníková R
    Gen Physiol Biophys; 2010 Dec; 29(4):319-40. PubMed ID: 21156995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between nitric oxide and angiotensin II in the endothelium: role in atherosclerosis and hypertension.
    Schulman IH; Zhou MS; Raij L
    J Hypertens Suppl; 2006 Mar; 24(1):S45-50. PubMed ID: 16601573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Renin-angiotensin system in atherosclerosis].
    Fukuda D; Sata M
    Nihon Rinsho; 2006 Apr; 64(4):805-9. PubMed ID: 16613201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Critical role of renin-angiotensin system in the pathogenesis of atherosclerosis].
    Hirata Y; Fukuda D; Sata M
    Nihon Rinsho; 2011 Jan; 69(1):55-9. PubMed ID: 21226261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular protection: current possibilities and future perspectives.
    Lüscher TF
    Int J Clin Pract Suppl; 2001 Jan; (117):3-6. PubMed ID: 11715356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelin receptor-mediated vasodilatation: effects of organ culture.
    Nilsson D; Wackenfors A; Gustafsson L; Ugander M; Paulsson P; Ingemansson R; Edvinsson L; Malmsjö M
    Eur J Pharmacol; 2008 Jan; 579(1-3):233-40. PubMed ID: 17964568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin--role in vascular disease.
    Abraham D; Dashwood M
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v23-4. PubMed ID: 18784133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.